Lynch syndrome (HNPCC)

Hereditary Cancer in Clinical Practice

Volumn 6, Issue 2, 2008, Pages 99-102

  Kładny, Józef ^a   Lubiński, Jan ^b  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b International Hereditary Cancer Centre   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ASCORBIC ACID; CALCIUM; MISMATCH REPAIR PROTEIN PMS2; PIROXICAM; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; SULINDAC;

ADENOMATOUS POLYP; CLINICAL FEATURE; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; DIET THERAPY; ECHOGRAPHY; ENDOSCOPIC POLYPECTOMY; FAMILIAL CANCER; GARDNER SYNDROME; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; JUVENILE POLYP; PEUTZ JEGHERS SYNDROME; SHORT SURVEY; TUMOR LOCALIZATION; TURCOT SYNDROME;

EID: 46449106383     PISSN: 17312302     EISSN: None     Source Type: Journal    
DOI: 10.1186/1897-4287-6-2-99     Document Type: Short Survey

References (23)

1. Lovett E. Family studies in cancer of the colon and rectum. Br J Surg 1976; 63: 13-18.
2. Lynch HT, Lynch J, Lynch P. Management and control of familial cancer. In: Mulvill JJ, Miller RW, Fraumeni JF (eds.). Genetics of Human Cancer. New York, Raven Press, 1977; 3: 235-255.
3. Ponz de Leon M, Sassatelli R, Sacchetti C, Zanghieri G, Scalmati A, Roncucci L. Familial aggregation of tumors in the three-year experience of a population-based colorectal cancer registry. Cancer Res 1989; 49: 4344-4348.
4. Lynch HT, Smyrk T, Watson P, Lanspa St, Boman B, Lynch P, Lynch J, Cavalieri J. Hereditary colorectal cancer. Seminars in Oncology 1991; 18: 337-366.
5. Vasen H. Inherited forms of colorectal, breast, and ovarian cancer. Surg Oncol Clin N Am 1994; 3: 501.
6. Lynch HT, Krush AJ. Cancer family "G" revisited: 1895-1970. Cancer 1971; 27: 1505-1511.
7. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993; 75: 1027-1038.
8. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomaki P, Sistonen P, Aaltonen LA, Nystrom-Lahti M, Guan XY, Zhang J, Meltzer PS, Yu J-W, Kao F-T, Chen DJ, Cerosaletti KM, Fournier REK, Todd S, Lewis T, Leach RJ, Naylor SL, Weissenbach J, Mecklin JP, Järvinen H, Peterson GM, Hamilton SR, Green J, Jass J, Watson P, Lynch HT, Trent JM, De la Chapelle A, Kinzler KW, Vogelstein B. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993; 75: 1215-1225.
9. Nicolaides NC, Papadopoulos N, Liu B, Wei Y-F, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Dunlop MG, Hamilton SR, Petersen GM, De la Chapelle A, Vogelstein B, Kinzler KW. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994; 371: 75-80.
10. Papadopoulos N, Nicolaides NC, Wei Y-F, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Hamilton SR, Petersen GM, Watson P, Lynch HT, Peltomaki P, Mecklin JP, De la Chapelle A, Kinzler KW, Vogelstein B. Mutation of a mutL homolog in hereditary colon cancer. Science 1994; 263: 1625-1629.
11. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34: 424-425.
12. Vasen HF, Watson P, Mecklin JP, Lynch H, and the ICG-HNPCC. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999; 116: 1453-1456.
13. Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L, Srivastava S. A National Cancer Institute Workshop on Hereditary Non-polyposis Colorectal Cancer Syndrome: meeteng highlights and Bethesda Guidelines. J Natl Cancer Inst 1997; 89: 1758-1762.
14. Park JG, Vasen HF, Park KJ, Peltomaki P, et al. Suspected hereditary nonpolyposis colorectal cancer. Dis Colon Rectum 1999; 42: 710-716.
15. Park JG, Vasen HF, Park YJ, Park KJ, Peltomaki P, de Leon MP, Rodriguez-Bigas MA, Lubinski J, Beck NE, Bisgaard ML, Miyaki M, Wijnen JT, Baba S, Lindblom A, Madlensky L, Lynch HT. Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study. Int J Colorectal Dis 2002; 17: 109-114.
16. Vasen HF, Mecklin JP, Watson P, Utsunomiya J, Bertario L, Lynch P, Svendsen LB, Cristofaro G, Müller HJ, Khan PM, Lynch HT. Surveillance in Hereditary Nonpolyposis Colorectal Cancer: an international cooperative study of 165 families. The International Collaborative Group on HNPCC. Dis Colon Rectum 1993; 36: 1-4.
17. Lynch HT, Lynch J. Lynch syndrome: natural history, genetic counseling and prevention. J Clin Oncol 2000; 18 (21 Suppl): 19S-31S.
18. Willet WC, Stampfer MJ, Colditz GA, Rosner BA, Speizer FE. Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 1990; 323: 1664-1672.
19. Bralow SP. Primary and secondary chemoprevention of colorectal cancer: Hereditary colorectal cancer. Springer Verlag Tokyo 1990; 231.
20. Muscat JE, Stellman SD, Wynder EL. Nonsteroidal antiinflammatory drugs and colorectal cancer. Cancer 1994; 74: 1847-1854.
21. Vasen HF, Nagengast FM, Khan PM. Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome). Lancet 1995; 345: 1183-1184.
22. Watson P, Vasen HF, Mecklin JP, Järvinen H, Lynch HT. The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. Am J Med 1994; 96: 516-520.
23. Järvinen HJ, Aamio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomäki P, De La Chapelle A, Mecklin JP. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000; 118: 829-834.